Ayalon Insurance Company’s Gilead Sciences GILD Stock Holding History

Ayalon Insurance Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,150	Closed	-$218K	–	144
2021 Q2	$218K	Hold	3,150	–	–	0.07%	113
2021 Q1	$209K	Buy	+3,150	New	+$203K	0.08%	98
2020 Q2	–	Sell	-755	Closed	-$55K	–	132
2020 Q1	$55K	Hold	755	–	–	0.04%	87
2019 Q4	$49K	Hold	755	–	–	0.03%	104
2019 Q3	$48K	Hold	755	–	–	0.03%	105
2019 Q2	$51K	Hold	755	–	–	0.03%	96
2019 Q1	$50K	Hold	755	–	–	0.04%	93
2018 Q4	$47K	Hold	755	–	–	0.04%	93
2018 Q3	$59K	Hold	755	–	–	0.05%	77
2018 Q2	$53K	Buy	+755	New	+$53.3K	0.04%	66
2016 Q4	$85K	Hold	1,190	–	–	0.07%	54
2016 Q3	$94K	Hold	1,190	–	–	0.08%	55
2016 Q2	$101K	Hold	1,190	–	–	0.09%	57
2016 Q1	$112K	Sell	1,190 -18,280	-94%	-$1.65M	0.09%	66
2015 Q4	$1.97M	Hold	19,470	–	–	1.66%	16
2015 Q3	$1.98M	Buy	19,470 +16,500	+556%	+$1.83M	1.65%	15
2015 Q2	$345K	Hold	2,970	–	–	0.25%	54
2015 Q1	$291K	Buy	+2,970	New	+$302K	0.18%	71

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ayalon Insurance Company's GILD Position: Q3 2021 in Review

Ayalon Insurance Company sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 3,150 shares — an estimated $218K sold.

Ayalon Insurance Company first reported a position in GILD in Q1 2015 and held it in 18 quarters. The position peaked at $1.98M in Q3 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Ayalon Insurance Company reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
Ayalon Insurance Company sold 3,150 Gilead Sciences shares in Q3 2021, an estimated $218K.
Ayalon Insurance Company first reported a position in Gilead Sciences in Q1 2015 and held it in 18 quarters.
Ayalon Insurance Company's Gilead Sciences position peaked at $1.98M in Q3 2015.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Ayalon Insurance Company's 13F filing for Q3 2021, filed 13 Oct 2021.